Pericytes support neutrophil transmigration via interleukin-8 across a porcine co-culture model of the blood-brain barrier

被引:73
作者
Pieper, Christian [1 ]
Pieloch, Paulina [1 ]
Galla, Hans-Joachim [1 ]
机构
[1] Univ Munster, Inst Biochem, D-48149 Munster, Germany
关键词
Blood-brain barrier; Pericyte; Neutrophil-migration; Inflammation; Matrix metalloproteinase; Co-culture; CAPILLARY ENDOTHELIAL-CELLS; GELATINASE B MMP-9; IN-VITRO; MICROVASCULAR PERICYTES; CEREBRAL-ISCHEMIA; ACTIVATION; EXPRESSION; MIGRATION; RELEASE; ALPHA;
D O I
10.1016/j.brainres.2013.05.047
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Transmigration of neuisophils across the blood-brain barrier (BBB) to an inflamed brain tissue is an important process during neuronal inflammation. The process of neutrophil activation as well as their way of rolling along the endothelium and their transmigration is quite well understood. Nevertheless, relatively little is known about the fate of neutrophils after they have transmigrated through the endothelium. The role of the other cells of the neurovascular unit in this process is also poorly understood. Here we studied the potential of pericytes to chemo-attract neutrophils under inflammatory conditions. Quantitative real time PCR, western blot analysis, and a chemotaxis assay showed that pericytes are able to chemo-attract neutrophils by interleukin-8 (IL-8) after stimulation with lipopolysaccharides (LPS), tumor necrosis factor-alpha (TNF-alpha), or interleuldn-1beta (IL-1 beta). Then, a co-culture model consisting of primary porcine brain capillary endothelial cells (PBCECs) and primary porcine brain capillary pericytes (PBCPs) was used to analyze neutrophil transmigration across the BBB. As a model for inflammation, LPS was used and the effects of the cytokines TNF-alpha, IL-1 beta, and interferon-gamma (IFN-gamma) were analyzed. In general, all stimulants apart from IFN-gamma were able to increase transendothelial neutrophil migration. This effect was significantly reduced by a specific inhibitor of matrix metalloproteinases (MMPs)-2 and -9. MMP-2/-9 secretion is expected to decrease adhesion to pericytes and thus support the transmigration of neutrophils. Additionally, in an adhesion experiment, we showed that MMP-2/-9 inhibition significantly enhances the adhesion of neutrophils to pericytes.(C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 52 条
[1]  
Abbott NJ, 2012, METHODS MOL BIOL, V814, P415, DOI 10.1007/978-1-61779-452-0_28
[2]  
Aiba Toyotaka, 1995, Neurologia Medico-Chirurgica, V35, P347, DOI 10.2176/nmc.35.347
[3]   Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis [J].
Ardi, Veronica C. ;
Kupriyanova, Tatyana A. ;
Deryugina, Elena I. ;
Quigley, James P. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (51) :20262-20267
[4]   Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises [J].
Armulik, Annika ;
Genove, Guillem ;
Betsholtz, Christer .
DEVELOPMENTAL CELL, 2011, 21 (02) :193-215
[5]  
Balabanov R, 1999, J NEUROSCI RES, V55, P578, DOI 10.1002/(SICI)1097-4547(19990301)55:5<578::AID-JNR5>3.0.CO
[6]  
2-E
[7]   CNS microvascular pericytes express macrophage-like function, cell surface integrin alpha M, and macrophage marker ED-2 [J].
Balabanov, R ;
Washington, R ;
Wagnerova, J ;
DoreDuffy, P .
MICROVASCULAR RESEARCH, 1996, 52 (02) :127-142
[8]   PHAGOCYTOSING NEUTROPHILS PRODUCE AND RELEASE HIGH AMOUNTS OF THE NEUTROPHIL-ACTIVATING PEPTIDE-1/INTERLEUKIN-8 [J].
BAZZONI, F ;
CASSATELLA, MA ;
ROSSI, F ;
CESKA, M ;
DEWALD, B ;
BAGGIOLINI, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03) :771-774
[9]   NITRIC-OXIDE SYNTHASE ACTIVITY AND EXPRESSION IN RETINAL CAPILLARY ENDOTHELIAL-CELLS AND PERICYTES [J].
CHAKRAVARTHY, U ;
STITT, AW ;
MCNALLY, J ;
BAILIE, JR ;
HOEY, EM ;
DUPREX, P .
CURRENT EYE RESEARCH, 1995, 14 (04) :285-294
[10]   Multiple roles for MMPs and TIMPs in cerebral ischemia [J].
Cunningham, LA ;
Wetzel, M ;
Rosenberg, GA .
GLIA, 2005, 50 (04) :329-339